Meeting
2016 ASCO Annual Meeting
Next generation sequencing (NGS) of primary central nervous system tumors (CNST) as part of a personalized medicine cancer research program (PMRP) to identify alterations with sensitivity to targeted inhibitors.
Authors
Tara L. Benkers
Swedish Neuroscience Institute, Seattle, WA
Tara L. Benkers , Anna Belinda Berry , Mariko Tameishi , Mary Lessig , Thomas David Brown
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 34, 2016 (suppl; abstr 2066)
DOI
10.1200/JCO.2016.34.15_suppl.2066
Abstract #
2066
Poster Bd #
253
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing in pancreatic cancer: Revealing genomic mutations beyond KRAS.
First Author: Andrea S. Teague
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib